Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Anbio Biotechnology (NASDAQ: NNNN)
NNNN Stock Predictions and Ratings
WSX Rating:
STRONG SELL
WSX Forecast (1yr):
-27.10%
Analyst Rating:
NOT AVAILABLE
Analyst Forecast (1yr):
NOT AVAILABLE
NNNN Stock Analysis
NNNN
PE Ratio:
193.9
NNNN
PEG Ratio:
Not Available
NNNN
Forward EPS Growth (12 month):
0.00%
NNNN
PS Ratio:
144.7
NNNN
PSG Ratio:
Not Available
NNNN
Forward Revenue Growth (12 month):
0.00%
NNNN Articles
No data was found